proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix)

There's growing concern that proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix).

At first many experts dismissed this because it was based on in vitro platelet aggregation studies...not clinical outcomes.

Now some new studies suggest that patients taking clopidogrel plus a PPI actually have more cardiovascular events.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote